Use of leflunomide in the treatment of polyomavirus BK-associated nephropathy

Annals of Pharmacotherapy

Volumn 42, Issue 11, 2008, Pages 1679-1685

  Wu, Judy K ^a   Harris, Matthew T ^a  

^a DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

BK virus; Leflunomide; Polyomavirus; Renal transplant

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CIDOFOVIR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; TERIFLUNOMIDE; THYMOCYTE ANTIBODY;

ANTIVIRAL ACTIVITY; BK VIRUS; BLOOD CELL COUNT; BV VIRUS ASSOCIATED NEPHROPATHY; DRUG MONITORING; DRUG SUBSTITUTION; GRAFT FAILURE; HUMAN; KIDNEY DISEASE; KIDNEY GRAFT; LIVER FUNCTION TEST; LOW DRUG DOSE; MEDLINE; PRIORITY JOURNAL; REVIEW; SCISEARCH; UNSPECIFIED SIDE EFFECT; VIREMIA;

BK VIRUS; HUMANS; ISOXAZOLES; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 55949136022     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L180     Document Type: Review

References (26)

1. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007;84:323-30.
2. Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006;69:655-62.
3. Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005;41:354-60.
4. Ahsan N. Polyomaviruses and human diseases. Georgetown, TX: Springer Science + Business Media; Eurekah.com/Landes Bioscience, 2006.
5. Bohl DL, Brennan DC. BK virus nephropathy and kidney transplantation. Clin J Am Soc Nephrol 2007;2(suppl 1):S36-46.
6. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of Polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002;347:488-96.
7. Duclos AJ, Krishnamurthi V, Lard M, et al. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients. Transplant Proc 2006;38:3666-72.
8. Hirsch HH. Polyomavirus BK nephropathy: a (re-) emerging complication in renal transplantation. Am J Transplant 2002;2:25-30.
9. Beimler J, Sommerer C, Zeier M. The influence of immunosuppression on the development of BK virus nephropathy - does it matter? Nephrol Dial Transplant 2007;22(suppl 8):viii66-71.
10. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005;79:1277-86.
11. Trofe J, Hirsch HH, Ramos E. Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients. Transpl Infect Dis 2006;8:76-85.
12. Blanckaert K, De Vriese AS. Current recommendations for diagnosis and management of polyoma BK virus nephropathy in renal transplant recipients. Nephrol Dial Transplant 2006;21:3364-7.
13. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis 2006;8:95-101.
14. Product information. Arava (leflunomide). Bridgewater, NJ: Avertis Pharmaceuticals, July 2007.
15. Williams JW, Mital D, Chong A, et al. Experiences with leflunomide in solid organ transplantation. Transplantation 2002;73:358-66.
16. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005;79:116-8.
17. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006;81: 704-10.
18. Zavos G, Gazouli M, Psimenou E, et al. Polyomavirus BK infection in Greek renal transplant recipients. Transplant Proc 2004;36:1413-4.
19. Crew RJ, Markowitz G, Radhakrishnan J. Therapeutic options in BK virus-associated interstitial nephritis. Kidney Int 2006;70:399-402.
20. Teschner S, Geyer M, Wilpert J, et al. Remission of polyomavirus-induced graft nephropathy treated with low-dose leflunomide. Nephrol Dial Transplant 2006;21:2039-40.
21. Ott U, Steiner T, Busch M, Gerth J, Wolf G. A single-center experience with BK virus nephropathy. Clin Nephrol 2008;69:244-50.
22. Bansal S, Lucia MS, Wiseman A. A case of polyomavirus-associated nephropathy presenting late after transplantation. Nat Clin Pract Nephrol 2008;4:283-7.
23. Leca N, Muczynski KA, Jefferson JA, et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol 2008;3:829-35.
24. Basse G, Mengelle C, Kamar N, et al. Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome. Transplant Proc 2007;39:84-7.
25. Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007;20:962-9.
26. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005;352:1157-8.